| Primary information |
|---|
| sequence ID | Seq_154 |
| Peptide sequence | ADDTWEPFASGK |
| CancerPDF_ID | CancerPDF_ID334, CancerPDF_ID2106, CancerPDF_ID3201, |
| PMID | 19795908,21136997,21136997 |
| Protein Name | Transthyretin,Transthyretin,Transthyretin |
| UniprotKB Entry Name | TTHY_HUMAN,TTHY_HUMAN,TTHY_HUMAN |
| Fluid | Plasma,Serum,Plasma |
| M/Z | 662.293,1322.5779,1322.5779 |
| Charge | 2,1,1 |
| Mass (in Da) | NA,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,LC-MS,LC-MS |
| Peptide Identification technique | MALDI-TOF/TOF,LC-MS-MS/MS,LC-MS-MS/MS |
| Quantification Technique | LC-MRM (multiple reaction monitoring),LC-ESI-MS,LC-ESI-MS |
| Labelled/Label Free | Labelled,Label Free,Label Free |
| FDR | less than 7%,NA,NA |
| CancerPDF_ID | CancerPDF_ID334, CancerPDF_ID2106, CancerPDF_ID3201, |
| p-Value | NA,NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),MASCOT(v. 2.2.01) |
| Length | 12,12,12 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Normal |
| Database | NCBI refseq Protein Database,SwissProt Database,SwissProt Database |
| Modification | NA,NA,NA |
| Number of Patients | "41 normal, 24 patients",30 patients and 30 healthy controls,27 healthy individuals |
| Regulation | NA,NA,NA |
| Validation | NA,Leave One out Cross validation,Leave One out Cross validation |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |